Missouri Regulators Issue Recall of Over 62,000 Marijuana Products

The Missouri Division of Cannabis Regulation (MDCR) has issued a recall covering more than 62,000 different marijuana products throughout the state.

The MDCR says they are “issuing a patient and consumer communication to alert patients and consumers about a mandatory product recall” affecting “manufactured products sold to dispensaries and manufacturers by infused product manufacturer, Delta Extraction, LLC, MAN000022.”

The agency says the “recalled products were not compliantly tracked in the statewide track and trace system (METRC) in order for [Division of Cannabis Regulation] to verify the products came from marijuana grown in Missouri or that the product passed required testing prior to being sold at dispensaries.”

No “adverse reactions for this product have been reported to the agency at this time,” but they say that consumers “who have purchased the recalled product should discontinue use.”

“All unused product(s) should be discarded or returned to the dispensary where purchased”, said the agency in a press release. “Returned products will not count toward a patient’s purchase limit. For more information on returns, please contact the dispensary where the product was purchased”.

A list of all 62,800 recalled products can be found on the Missouri Department of Health and Human Services’ website.

July marked the sixth straight month in Missouri where marijuana sales passed $100 million, with $123.2 million in sales.

Thank you for reading The Marijuana Herald! You can find more news stories by clicking here, and you can sign up for daily news updates by clicking here

 

More articles from The Marijuana Herald can be found below.

Washington, D.C. Medical Marijuana Sales Hit $100.9 Million in 2025 as Patient Count Grows to Nearly 100,000

Washington, D.C. Medical Marijuana Sales Hit $100.9 Million in 2025 as Patient Count Grows to Nearly 100,000

Connecticut Sets New Monthly Marijuana Sales Record in December as Prices Hit All-Time Low

Connecticut Sets New Monthly Marijuana Sales Record in December as Prices Hit All-Time Low

Study: CBD Shows Potent Antibacterial Activity Against Drug-Resistant Enterococcus Strains

Study: CBD Shows Potent Antibacterial Activity Against Drug-Resistant Enterococcus Strains

Study: Hemp Seed Extracts May Enhance Effectiveness of Antibiotics and Antifungal Medications

Study: Hemp Seed Extracts May Enhance Effectiveness of Antibiotics and Antifungal Medications

Study: CBD Gel Reduced Jaw Muscle Activity in Adults With Temporomandibular Disorders

Study: CBD Gel Reduced Jaw Muscle Activity in Adults With Temporomandibular Disorders

Indiana Senate Bill Would Legalize Recreational Marijuana, Including Licensed Sales

Indiana Senate Bill Would Legalize Recreational Marijuana, Including Licensed Sales

Low-Dose CBD Protected Developing Heart From Oxygen-Related Injury in Newborn Animal Study

Low-Dose CBD Protected Developing Heart From Oxygen-Related Injury in Newborn Animal Study

Randomized Controlled Trial Finds CBD May Reduce Anxiety and Perceived Effort in Runners

Randomized Controlled Trial Finds CBD May Reduce Anxiety and Perceived Effort in Runners

Study: Cannabis Extract Triggered Cell Death and Reduced Invasion in Human Breast Cancer Cells

Study: Cannabis Extract Triggered Cell Death and Reduced Invasion in Human Breast Cancer Cells

Vermont Bill Would Require Cities to Vote on Allowing Marijuana Stores During 2026 Election

Vermont Bill Would Require Cities to Vote on Allowing Marijuana Stores During 2026 Election

Tilray Brands Posts Record $217.5M Q2 Revenue

Tilray Brands Posts Record $217.5M Q2 Revenue

Study: CBD Reduced Bladder Pain and Inflammation in Animal Model of Interstitial Cystitis

Study: CBD Reduced Bladder Pain and Inflammation in Animal Model of Interstitial Cystitis

CBD Reduces Bacteria That Causes Gum Disease, Finds New Lab Study

CBD Reduces Bacteria That Causes Gum Disease, Finds New Lab Study

New York Bill Would Give Cannabis Distributors More Time to File Quarterly Tax Returns

New York Bill Would Give Cannabis Distributors More Time to File Quarterly Tax Returns

New Hampshire: Bipartisan Psilocybin Bills Scheduled for Public Hearing on January 14

New Hampshire: Bipartisan Psilocybin Bills Scheduled for Public Hearing on January 14

Maine Marijuana Sales Reach $246 Million in 2025, With 4.8 Million Transactions

Maine Marijuana Sales Reach $246 Million in 2025, With 4.8 Million Transactions

Study: Marijuana Appears in 37% of U.S. Hip-Hop Music Videos

Study: Marijuana Appears in 37% of U.S. Hip-Hop Music Videos

Study: CBD-Rich Cannabis Oil Linked to Reduced ADHD Symptoms in Children and Young Adults With Autism

Study: CBD-Rich Cannabis Oil Linked to Reduced ADHD Symptoms in Children and Young Adults With Autism